Skip to main content

Christopher A. Posner

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Christopher A. Posner

Christopher A. Posner is recorded as Board Member at Zevra Therapeutics, Inc. (ZVRA). Zevra Therapeutics, Inc. reported in an 8-K filed November 29, 2022 that Christopher A. Posner was appointed director, effective November 28, 2022.

“On November 28, 2022, the board of directors (the “Board”) of KemPharm, Inc. (the “Company”) appointed Christopher A. Posner to serve as a director of the Company, effective immediately.”
Zevra Therapeutics, Inc. Form 8-K, filed November 29, 2022 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Zevra Therapeutics, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.